Table 1. Patient characteristics and outcomes following FTRD.

Patient no.	Sex	Age (yrs)	Indication	Histology	Location	Size mm	Time(min)	R0	Follow up (mo)	Hospital stay	Complication	Macroscopic recurrence	Microscopic recurrence	Surgery
1	M	51	Paradiverticular adenoma	LG IEN	Caecum	23	120	y	3	3	n	y	n	n
2	F	76	Relapse after EMR	HG IEN	Rectum	15	80	y	6	4	n	y	n	n
3	F	65	Non lifting LST	LG IEN,	Ascending colon	25	105	y	3	5	y	y	y	n
4	M	55	NET with submucosal infiltration	Fibrosis	Rectum	15	25	y	1	1	n	n	n	n
5	M	59	Non lifting LST with central depression	LG IEN	Rectum	19	25	y	12	2	n	y	y	n
5 bis	M	60	Adenoma relapse	pT1	Rectum	13	20	x	12	2	n	n	n	y
6	M	74	non lifting adenoma	HG IEN	Right Flexure	14	125	x	8	2	n	y	n	n
7	M	71	non lifting adenoma after polypectomy	LG IEN	Ascending colon	12	50	y	5	3	n	n	n	n
8	F	68	non lifting adenoma	Fibrosis without dysplasia	Right Flexure	16	65	n/a	15	1	n	y	y	y
9	F	60	non lifting adenoma	LG IEN	Caecum	12	65	y	3	4	y	y	n	n
10	M	68	non lifting adenoma	HG IEN	Rectum	21	35	y	27	2	n	n	n	n
11	M	64	partial adenoma resection	pT1 sm1	Left flexure	18	105	y	10	3	n	y	n	n
12	F	65	Residual adenoma after EMR	SSA	Rectum	20	65	y	n/a	1	n	n/a	n/a	n

No, number; n/a, not assessed/not applicable; X, not evaluable; yrs, years; min, minutes; mo, months; EMR, endoscopic mucosal resection; LST, lateral spreading tumor; NET, neuroendocrine tumor; R0, complete resection; FTR, full-thickness resection; SSA sessile serrate adenoma.